Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON43969
NL-OMON43969
Completed
Not Applicable

The supplementary role of cardiovascular magnetic resonance imaging and computed tomography angiography to routine clinical practice in suspected non-ST elevation myocardial infarction. A randomized controlled trial. - Non-invasive imaging in suspected NSTEMI CARMENTA trial

Medisch Universitair Ziekenhuis Maastricht0 sites207 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsNon-ST elevation myocardial infarction - Heart attack10028593

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non-ST elevation myocardial infarction - Heart attack
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
207
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Trial ended prematurely

Registry
who.int
Start Date
TBD
End Date
June 19, 2017
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • •\*Prolonged symptoms suspected of cardiac origin (angina pectoris or angina
  • •equivalent), and presentation on the cardiac ED \<24 hours after symptom onset
  • •\*Increased highly sensitive troponin\-T level (hs\-TnT \*0\.014\*g/L) (initial blood sample at presentation or a second sample \*3 hours after presentation)
  • •\*Age 18 years \* 85 years
  • •\*Willing and capable to give written informed consent
  • •\*Written informed consent

Exclusion Criteria

  • •\*Ongoing severe ischemia requiring immediate ICA (at discretion of cardiac ED
  • •physician/cardiologist)
  • •\*Shock (mean arterial pressure \< 60 mmHg) or severe heart failure (Killip Class \* III)
  • •\*STEMI (ST\-elevation in 2 contiguous leads: \*0\.2mV in men or \*0\.15 mV in women in leads V2\-V3
  • •and/or \*0\.1 mV in other leads or new left bundle branch block)
  • •\*Chest pain highly suggestive of non\-cardiac origin (as judged by the cardiac ED
  • •physician/cardiologist):
  • •o Acute aortic dissection
  • •o Acute pulmonary embolism (high risk patient defined as Wells score \>6\)
  • •o Musculoskeletal or gastro\-intestinal pain

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Evaluation of Heart Failure with preserved Ejection Fraction and peripheral microvascular dysfunctiobloedvataandoeningen, verminderde functie van microcirculatieHeart failure with preserved ejection fractionheart failure with preserved pump function10019280
NL-OMON55466Medisch Universitair Ziekenhuis Maastricht2,278
Completed
Not Applicable
The value of echocardiography for prediction of radiation-induced lung injury in non-small cell lung cancer patients treated with chemo radiation: an onco-cardiac prospective cohort study.malignant lungtumournon-small lung cancer stage I-III1008220610029107
NL-OMON47174MAASTRO clinic15
Completed
Not Applicable
Hemodynamic characterization of cardiac disease and aortopathy after valve sparing aortic root replacement, mechanical aortic valve implantation or septal myectomy: a 4D-flow MRI studyprosthetic heart valvevalve sparing aortic replacement10046973
NL-OMON43202Academisch Medisch Centrum44
Completed
Not Applicable
on-invasive Electrocardiographic Imaging of SyncAV with MPP: Understanding Optimized Programming for Cardiac Resynchronization Therapy
NL-OMON54206St. Jude Medical30
Completed
Not Applicable
Heart Failure with Preserved Ejection Fraction (HFpEF), a prospective cohorthartaandoeningen, falen van de hartfunctieHeart failure with preserved ejection fraction10082206
NL-OMON50023Academisch Medisch Centrum201